These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30951540)

  • 1. Using proteomics to advance the search for potential biomarkers for preeclampsia: A systematic review and meta-analysis.
    Nguyen TPH; Patrick CJ; Parry LJ; Familari M
    PLoS One; 2019; 14(4):e0214671. PubMed ID: 30951540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for implementation of first trimester screening for preeclampsia and fetal growth restriction in low resource settings.
    Lakshmy S; Ziyaulla T; Rose N
    J Matern Fetal Neonatal Med; 2021 Dec; 34(24):4082-4089. PubMed ID: 31900014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration.
    Khan GH; Galazis N; Docheva N; Layfield R; Atiomo W
    Hum Reprod; 2015 Jan; 30(1):133-48. PubMed ID: 25351721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profile of preeclampsia in the first trimester of pregnancy.
    Jacobo-Baca G; Salazar-Ybarra RA; Torres-de-la-Cruz V; Guzmán-López S; Elizondo-Omaña RE; Guzmán-López A; Vázquez-Barragán MÁ; Martínez-de-Villarreal LE
    J Matern Fetal Neonatal Med; 2022 Sep; 35(18):3446-3452. PubMed ID: 32957816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies.
    Ghaemi MS; Tarca AL; Romero R; Stanley N; Fallahzadeh R; Tanada A; Culos A; Ando K; Han X; Blumenfeld YJ; Druzin ML; El-Sayed YY; Gibbs RS; Winn VD; Contrepois K; Ling XB; Wong RJ; Shaw GM; Stevenson DK; Gaudilliere B; Aghaeepour N; Angst MS
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5621-5628. PubMed ID: 33653202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia.
    Lee SM; Kang Y; Lee EM; Jung YM; Hong S; Park SJ; Park CW; Norwitz ER; Lee DY; Park JS
    Sci Rep; 2020 Sep; 10(1):16142. PubMed ID: 32999354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
    Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
    Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester serum biomarker discovery study for early onset, preterm onset and preeclampsia at term.
    Beernink RHJ; Zwertbroek EF; Schuitemaker JHN; Cremers TIFH; Scherjon SA
    Placenta; 2022 Oct; 128():39-48. PubMed ID: 36058050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic proteomics analysis of lysine acetylation reveals critical features of placental proteins in pregnant women with preeclampsia.
    Shangguan Y; Wang Y; Shi W; Guo R; Zeng Z; Hu W; Cai W; Yan Q; Xu Y; Tang D; Dai Y
    J Cell Mol Med; 2021 Nov; 25(22):10614-10626. PubMed ID: 34697885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia?
    Khaliq OP; Konoshita T; Moodley J; Naicker T
    Curr Hypertens Rep; 2018 Jul; 20(9):80. PubMed ID: 29992361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of protein biomarkers in pre-eclampsia: the promising role of mass spectrometry.
    Dahabiyeh LA
    Biomarkers; 2018 Nov; 23(7):609-621. PubMed ID: 29737875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A label-free selected reaction monitoring workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia.
    Blankley RT; Fisher C; Westwood M; North R; Baker PN; Walker MJ; Williamson A; Whetton AD; Lin W; McCowan L; Roberts CT; Cooper GJ; Unwin RD; Myers JE
    Mol Cell Proteomics; 2013 Nov; 12(11):3148-59. PubMed ID: 23897580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA Copy Number in Peripheral Blood in the First Trimester of Pregnancy and Different Preeclampsia Clinical Phenotypes Development: A Pilot Study.
    Busnelli A; Lattuada D; Ferrari S; Reschini M; Colciaghi B; Somigliana E; Fedele L; Ferrazzi E
    Reprod Sci; 2019 Aug; 26(8):1054-1061. PubMed ID: 30296910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based proteomics for pre-eclampsia and preterm birth.
    Law KP; Han TL; Tong C; Baker PN
    Int J Mol Sci; 2015 May; 16(5):10952-85. PubMed ID: 26006232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.